{"pmid":32236089,"title":"Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR).","text":["Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR).","Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR) On February 2020, Italy, especially the northern regions, was hit by an epidemic of the new SARS-Cov-2 coronavirus that spread from China between December 2019 and January 2020. The entire healthcare system had to respond promptly in a very short time to an exponential growth of the number of subjects affected by COVID-19 (Coronavirus disease 2019) with the need of semi-intensive and intensive care units.","Monaldi Arch Chest Dis","Lazzeri, Marta","Lanza, Andrea","Bellini, Raffaella","Bellofiore, Angela","Cecchetto, Simone","Colombo, Alessia","D'Abrosca, Francesco","Del Monaco, Cesare","Gaudiello, Giuseppe","Paneroni, Mara","Privitera, Emilia","Retucci, Mariangela","Rossi, Veronica","Santambrogio, Martina","Sommariva, Maurizio","Frigerio, Pamela","32236089"],"abstract":["Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR) On February 2020, Italy, especially the northern regions, was hit by an epidemic of the new SARS-Cov-2 coronavirus that spread from China between December 2019 and January 2020. The entire healthcare system had to respond promptly in a very short time to an exponential growth of the number of subjects affected by COVID-19 (Coronavirus disease 2019) with the need of semi-intensive and intensive care units."],"journal":"Monaldi Arch Chest Dis","authors":["Lazzeri, Marta","Lanza, Andrea","Bellini, Raffaella","Bellofiore, Angela","Cecchetto, Simone","Colombo, Alessia","D'Abrosca, Francesco","Del Monaco, Cesare","Gaudiello, Giuseppe","Paneroni, Mara","Privitera, Emilia","Retucci, Mariangela","Rossi, Veronica","Santambrogio, Martina","Sommariva, Maurizio","Frigerio, Pamela"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32236089","week":"202014|Mar 30 - Apr 05","doi":"10.4081/monaldi.2020.1285","source":"PubMed","locations":["China","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1662996001627045888,"score":7.6048946,"similar":[{"pmid":32178769,"title":"COVID-19 and Italy: what next?","text":["COVID-19 and Italy: what next?","The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global response to prepare health systems worldwide is imperative. Although containment measures in China have reduced new cases by more than 90%, this reduction is not the case elsewhere, and Italy has been particularly affected. There is now grave concern regarding the Italian national health system's capacity to effectively respond to the needs of patients who are infected and require intensive care for SARS-CoV-2 pneumonia. The percentage of patients in intensive care reported daily in Italy between March 1 and March 11, 2020, has consistently been between 9% and 11% of patients who are actively infected. The number of patients infected since Feb 21 in Italy closely follows an exponential trend. If this trend continues for 1 more week, there will be 30 000 infected patients. Intensive care units will then be at maximum capacity; up to 4000 hospital beds will be needed by mid-April, 2020. Our analysis might help political leaders and health authorities to allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. If the Italian outbreak follows a similar trend as in Hubei province, China, the number of newly infected patients could start to decrease within 3-4 days, departing from the exponential trend. However, this cannot currently be predicted because of differences between social distancing measures and the capacity to quickly build dedicated facilities in China.","Lancet","Remuzzi, Andrea","Remuzzi, Giuseppe","32178769"],"abstract":["The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global response to prepare health systems worldwide is imperative. Although containment measures in China have reduced new cases by more than 90%, this reduction is not the case elsewhere, and Italy has been particularly affected. There is now grave concern regarding the Italian national health system's capacity to effectively respond to the needs of patients who are infected and require intensive care for SARS-CoV-2 pneumonia. The percentage of patients in intensive care reported daily in Italy between March 1 and March 11, 2020, has consistently been between 9% and 11% of patients who are actively infected. The number of patients infected since Feb 21 in Italy closely follows an exponential trend. If this trend continues for 1 more week, there will be 30 000 infected patients. Intensive care units will then be at maximum capacity; up to 4000 hospital beds will be needed by mid-April, 2020. Our analysis might help political leaders and health authorities to allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. If the Italian outbreak follows a similar trend as in Hubei province, China, the number of newly infected patients could start to decrease within 3-4 days, departing from the exponential trend. However, this cannot currently be predicted because of differences between social distancing measures and the capacity to quickly build dedicated facilities in China."],"journal":"Lancet","authors":["Remuzzi, Andrea","Remuzzi, Giuseppe"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32178769","week":"202012|Mar 16 - Mar 22","doi":"10.1016/S0140-6736(20)30627-9","source":"PubMed","locations":["Hubei","China","Italian","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1662334543590326273,"score":176.79738},{"pmid":32223063,"title":"Italian Society of Interventional Cardiology (GISE) Position Paper for Cath lab-specific Preparedness Recommendations for Healthcare providers in case of suspected, probable or confirmed cases of COVID-19.","text":["Italian Society of Interventional Cardiology (GISE) Position Paper for Cath lab-specific Preparedness Recommendations for Healthcare providers in case of suspected, probable or confirmed cases of COVID-19.","COVID-19 pandemic raised the issue to guarantee the proper level of care to patients with acute cardiovascular diseases and concomitant suspected or confirmed COVID-19 and, in the meantime safety and protection of healthcare providers. The aim of this position paper is to provide standards to healthcare facilities and healthcare providers on infection prevention and control measures during the management of suspected and confirmed cases of 2019-nCoV infection accessing in cath-lab. The document represents the view of the Italian Society of Interventional Cardiology (GISE), and it is based on recommendations from the main World and European Health Organizations (WHO, and ECDC) as well as from the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI). This article is protected by copyright. All rights reserved.","Catheter Cardiovasc Interv","Tarantini, Giuseppe","Fraccaro, Chiara","Chieffo, Alaide","Marchese, Alfredo","Tarantino, Fabio Felice","Rigattieri, Stefano","Limbruno, Ugo","Mauro, Ciro","La Manna, Alessio","Castiglioni, Battistina","Longoni, Matteo","Berti, Sergio","Greco, Francesco","Musumeci, Giuseppe","Esposito, Giovanni","32223063"],"abstract":["COVID-19 pandemic raised the issue to guarantee the proper level of care to patients with acute cardiovascular diseases and concomitant suspected or confirmed COVID-19 and, in the meantime safety and protection of healthcare providers. The aim of this position paper is to provide standards to healthcare facilities and healthcare providers on infection prevention and control measures during the management of suspected and confirmed cases of 2019-nCoV infection accessing in cath-lab. The document represents the view of the Italian Society of Interventional Cardiology (GISE), and it is based on recommendations from the main World and European Health Organizations (WHO, and ECDC) as well as from the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI). This article is protected by copyright. All rights reserved."],"journal":"Catheter Cardiovasc Interv","authors":["Tarantini, Giuseppe","Fraccaro, Chiara","Chieffo, Alaide","Marchese, Alfredo","Tarantino, Fabio Felice","Rigattieri, Stefano","Limbruno, Ugo","Mauro, Ciro","La Manna, Alessio","Castiglioni, Battistina","Longoni, Matteo","Berti, Sergio","Greco, Francesco","Musumeci, Giuseppe","Esposito, Giovanni"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32223063","week":"202014|Mar 30 - Apr 05","doi":"10.1002/ccd.28888","source":"PubMed","locations":["Italian","Analgesia"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1662715354809368577,"score":148.84819},{"pmid":32243677,"title":"The COVID-19 outbreak in Italy: initial implications for organ transplantation programs.","text":["The COVID-19 outbreak in Italy: initial implications for organ transplantation programs.","The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19 and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource.","Am J Transplant","Angelico, R","Trapani, S","Manzia, T M","Lombardini, L","Tisone, G","Cardillo, M","32243677"],"abstract":["The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19 and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource."],"journal":"Am J Transplant","authors":["Angelico, R","Trapani, S","Manzia, T M","Lombardini, L","Tisone, G","Cardillo, M"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243677","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15904","source":"PubMed","locations":["Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663079112859713536,"score":137.47534},{"pmid":32081636,"title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.","text":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond.","Int J Antimicrob Agents","Lai, Chih-Cheng","Shih, Tzu-Ping","Ko, Wen-Chien","Tang, Hung-Jen","Hsueh, Po-Ren","32081636"],"abstract":["The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond."],"journal":"Int J Antimicrob Agents","authors":["Lai, Chih-Cheng","Shih, Tzu-Ping","Ko, Wen-Chien","Tang, Hung-Jen","Hsueh, Po-Ren"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32081636","week":"20208|Feb 17 - Feb 23","doi":"10.1016/j.ijantimicag.2020.105924","keywords":["2019-nCoV","COVID-19","China","Epidemic","Remdesivir","SARS-CoV-2"],"source":"PubMed","locations":["China","USA","Wuhan"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Prevention","Transmission","Treatment"],"weight":1,"_version_":1662334544370466817,"score":118.52334},{"pmid":32238613,"title":"Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","text":["Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation are essential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19.","Indian Pediatr","Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan","32238613"],"abstract":["The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation are essential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19."],"journal":"Indian Pediatr","authors":["Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238613","week":"202014|Mar 30 - Apr 05","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662996001737146368,"score":116.48994}]}